Filing Flows

Filing Flows › Omnicell (OMCL) › Q3 2026

Omnicell (OMCL) Q3 2026 earnings results (third quarter 2026)

10-Q filed Nov 4, 2026

Omnicell (OMCL) reported revenue of $308M for the third quarter 2026 (Q3 2026), -0.9% from a year earlier and -1% from the quarter before. Operating margin was 4.9%, net earnings $11.0M (3.6% of revenue).

Revenue$308M
Year over year-0.9%
Quarter over quarter-1%
Operating margin4.9%
Net earnings$11.0M

Omnicell, Q3 2026: revenue $308M (-0.9% year over year), operating margin 4.9%, net earnings $11.0M, operating cash flow $33.1M. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$308M-1%-0.9%
Gross profit$138M-10%+2%
Operating profit$14.9M-54%+81%
Net earnings$11.0M-55%+102%
Operating cash flow$33.1M-52%+17%
Free cash flow$21.7M-63%+17%

What changed

Revenue was $307.9M in Q3 2026, down 1% year over year and down 1% from the previous quarter. Connected devices, software licenses, and other was the largest line at 47% of revenue. Connected devices, software licenses, and other lost $6.5M year over year (down 4%), 232% of the total change.

Gross margin was 44.8%, up 1.5 points from Q3 2025. Operating profit was $14.9M, a 4.9% margin (up 2.2 points year over year). Operating expenses fell 3% while revenue fell 1%. Net earnings were $11.0M, up 102% year over year. The effective tax rate was 30.1%.

Operating cash flow was $33.1M (up 17% year over year), 299% of net earnings. Non-cash charges added back $18.4M of depreciation and amortization and $11.4M of share-based compensation. Working capital and other items used $7.8M. Capital expenditures of $11.4M left free cash flow of $21.7M.

Questions

What was Omnicell's revenue in the third quarter 2026?

Omnicell (OMCL) reported revenue of $308M for the third quarter 2026 (Q3 2026), -0.9% from a year earlier and -1% from the quarter before.

Was Omnicell profitable in the third quarter 2026?

Operating profit was $14.9M (4.9% of revenue) and net earnings $11.0M.

Open the interactive Sankey →

Source: Omnicell 10-Q on SEC EDGAR.